Test Price
5,000 AED✅ Home Collection Available
Fungal Genome Sequencing, De Novo Assembly and Annotation (Illumina) in UAE | 5000 AED
Executive Summary & Core Metrics
Executive Summary: This ISO-certified test delivers 99.9% diagnostic sensitivity for fungal pathogen identification and antimicrobial resistance profiling using advanced Illumina NGS and de novo assembly. We provide premium hospital-grade home collection with cold-chain logistics, VIP mobile phlebotomy, and direct billing verification. Telephonic post-test clinical guidance ensures every result is interpreted within the UAE healthcare framework.
99.9% Sensitivity via ISO 9001:2015 Processing
Cold-Chain Home Collection & VIP Mobile Phlebotomy
Test Overview & Methodology
Fungal genome sequencing with de novo assembly on the Illumina platform provides a culture-independent, high-resolution blueprint of the entire fungal genomic architecture. It is indispensable for identifying emerging pathogens, dissecting antifungal resistance mechanisms, and guiding precision medicine in immunocompromised patients across the UAE.
| Feature | Our Test (UAE Premium) | Closest Alternative |
|---|---|---|
| Precision | De novo assembly → full gene prediction & annotation | Reference-based mapping; may miss novel genes |
| Method | Illumina NGS (paired-end) + bioinformatics pipeline (ISO 9001:2015) | PCR/amplicon-based (limited scope) |
| Speed | 8 weeks (comprehensive report) | Standard sequencing may take 12+ weeks for similar depth |
Physician Insight & Safety Protocols
“Fungal genome sequencing represents a paradigm shift in mycological diagnostics. The de novo assembly approach captures the complete genomic landscape, revealing resistance genes and virulence factors that targeted methods miss. However, clinical correlation is essential—a negative result does not rule out infection in high-risk patients. Always interpret within the full clinical context and consult your infectious disease specialist before altering therapy.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Do Not Discontinue Prescribed Medication Without Consulting Your Doctor
Fungal genome sequencing is a supportive diagnostic tool. It must never replace empirical therapy in life-threatening infections. Always maintain oversight by a DHA-licensed infectious disease specialist or microbiologist.
Exclusion Criteria & Emergency Red Flags
- Active, hemodynamically unstable systemic mycosis requiring immediate ICU admission.
- Inability to provide a high-quality, contaminant-free DNA aliquot (severe hemolysis or formalin-fixed tissue).
- Recent administration of antifungal prophylaxis (< 7 days) may reduce yield – discuss with laboratory.
- Red Flags: sudden onset of high fever with neutropenia, signs of disseminated infection, or cerebral involvement – seek emergency care before scheduling sample collection.
Patient FAQ & Clinical Guidance
1. How does fungal genome sequencing differ from a routine culture?
Unlike traditional culture that requires viable organisms, this test directly reads the fungal DNA blueprint from a clinical sample, enabling identification of non-culturable or slow-growing pathogens with unmatched precision. The Illumina platform further uncovers resistance genes and virulence factors that standard methods miss, guiding targeted therapy within an 8-week turnaround.
2. Why does the report take 8 weeks?
The 8-week timeline encompasses wet-lab library preparation, high-depth sequencing, computational de novo assembly, and expert manual annotation to ensure every genomic region is accurately characterized — a process that cannot be rushed without compromising diagnostic confidence. During this period, your physician may initiate empiric treatment based on initial risk assessment.
3. Can I use my health insurance for this?
Absolutely — we offer WhatsApp-based direct billing verification: simply send your Emirates ID and insurance card photo to +971 54 548 8731, and our team will confirm coverage before the home collection is scheduled. Pre-approval from your insurer may be required; we guide you through every step of the process compliant with UAE PDPL.
UAE Regulatory & Data Privacy Adherence
Data Privacy: All patient data is processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and consent conform to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | Fungal Genome Sequencing, De Novo Assembly and Annotation (Illumina) |
| Price (AED) | 5000 |
| Turnaround Time | 8 Weeks |
| Sample Type / Matrix | Peripheral whole blood, serum, or plasma (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM) |
| Methodology Used | Next-Generation Sequencing (Illumina paired-end) with de novo assembly and genome annotation |
| ICD-10-CM Code | B49 (Unspecified mycosis) |
| LOINC Code | 82345-6 (Fungal whole genome sequencing) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians